• Supply API 99% CAS 913611-97-9 Brexpiprazole Powder
  • Supply API 99% CAS 913611-97-9 Brexpiprazole Powder
  • Supply API 99% CAS 913611-97-9 Brexpiprazole Powder
  • Supply API 99% CAS 913611-97-9 Brexpiprazole Powder
  • Supply API 99% CAS 913611-97-9 Brexpiprazole Powder
  • Supply API 99% CAS 913611-97-9 Brexpiprazole Powder

Supply API 99% CAS 913611-97-9 Brexpiprazole Powder

Powder: Yes
Customized: Non-Customized
Certification: GMP, HSE, ISO 9001, USP, BP
Suitable for: Elderly, Children, Adult
State: Powder
Purity: >99%
Samples:
US$ 20/kg 1 kg(Min.Order)
| Request Sample
Customization:
Gold Member Since 2022

Suppliers with verified business licenses

Manufacturer/Factory
  • Overview
  • Product Description
  • Function
  • Detailed Photos
  • Related Product
  • Packaging & Shipping
Overview

Basic Info.

Model NO.
HMJ-Brexpiprazole
Color
White
Mf
C25h27n3o2s
Einecs
811-628-7
Test
HPLC
MW
433.57
CAS
913611-97-9
Shelf Life
2 Years
Grade
Pharmaceutical Grade
Transport Package
Ziplock Foil Bag. Drum
Specification
1kg Per Foil Bag, 10 Bags Per Carton, 25 Kg Per Dr
Trademark
HMJ
Origin
China
Production Capacity
200kg/Month

Product Description

Supply API 99% CAS 913611-97-9 Brexpiprazole Powder
Supply API 99% CAS 913611-97-9 Brexpiprazole Powder
Product Description

 

Product Name Supply API 99% CAS 913611-97-9 Brexpiprazole Powder
Appearance White powder
Molecular formula C25H27N3O2S
Molecular weight  433.57
Keywords Powder Brexpiprazole,Price Brexpiprazole; Pure Brexpiprazole
Shelf Life 24 months when properly stored
Storage Keep in a cool, dry, dark location
Function

What is Brexpiprazole?

Brexpiprazole is an atypical antipsychotic drug. It is a D2 dopamine partial agonist called serotonin-dopamine activity modulator (SDAM). The drug received FDA approval on July 13, 2015 for the treatment of schizophrenia, and as an adjunctive treatment for depression. Although Brexpiprazole failed Phase II clinical trials for ADHD, Brexpiprazole has been designed to provide improved efficacy and tolerability (e.g., less akathisia, restlessness and/or insomnia) over adjunctive treatments for major depressive disorder (MDD).

 

Function of Brexpiprazole?

The most common adverse events associated with brexpiprazole (all doses of brexpiprazole
cumulatively greater than or equal to 5% vs. placebo) were upper respiratory tract infection (6.9%
vs. 4.8%), akathisia (6.6% vs. 3.2%), weight gain (6.3% vs. 0.8%) and nasopharyngitis (5.0% vs. 1.6%).


Drug interactions Based on information given on the consent forms, Brexpiprazole seems
brexpiprazole is a substrate of CYP2D6 and CYP3A4, like its predecessor aripiprazole. Participants
in the clinical trials are advised to avoid grapefruit, Seville oranges and related citruses.

Detailed Photos


Supply API 99% CAS 913611-97-9 Brexpiprazole PowderSupply API 99% CAS 913611-97-9 Brexpiprazole Powder

 
Related Product

Supply API 99% CAS 913611-97-9 Brexpiprazole Powder

Packaging & Shipping


Supply API 99% CAS 913611-97-9 Brexpiprazole Powder

 

Supply API 99% CAS 913611-97-9 Brexpiprazole PowderSupply API 99% CAS 913611-97-9 Brexpiprazole PowderSupply API 99% CAS 913611-97-9 Brexpiprazole PowderSupply API 99% CAS 913611-97-9 Brexpiprazole Powder

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now